AC Immune (ACIU) Other Non Operating Income (2018 - 2026)
AC Immune (ACIU) reported Other Non Operating Income of -$224752.8 for Q1 2026, up 30.8% year-over-year from -$171832.2 in Q1 2025, and up 38.06% on a QoQ basis from -$362839.2 in Q4 2025.
AC Immune (ACIU) has 9 years of Other Non Operating Income data on file, last reported at -$224752.8 in Q1 2026.
- Quarterly Other Non Operating Income rose 30.8% year-over-year to -$224752.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$3.3 million (up 16.87% YoY) and the FY2025 annual result came in at -$3.4 million, down 85.33% from the prior year.
- Other Non Operating Income grew to -$224752.8 in Q1 2026 per ACIU's latest filing, from -$362839.2 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $2.2 million in Q4 2024 and bottomed at -$3.1 million in Q3 2024.
- The 5-year median for Other Non Operating Income is -$55139.3 (2023), against an average of -$387889.3.
- Peak annual rise in Other Non Operating Income reached 3451.49% in 2024, while the deepest fall reached 15460.19% in 2024.
- Tracing ACIU's Other Non Operating Income over 5 years: stood at -$113144.4 in 2022, then sank by 1361.7% to -$1.7 million in 2023, then soared by 235.63% to $2.2 million in 2024, then slumped by 116.18% to -$362839.2 in 2025, then jumped by 38.06% to -$224752.8 in 2026.
- Per Business Quant, the three latest ACIU Other Non Operating Income figures stand at -$224752.8 (Q1 2026), -$362839.2 (Q4 2025), and -$15001.3 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -224,752.82 |
| Dec 31, 2025 | -362,839.24 |
| Sep 30, 2025 | -15,001.31 |
| Jun 30, 2025 | -2.67 Mn |
| Mar 31, 2025 | -324,777.16 |
| Dec 31, 2024 | 2.24 Mn |
| Sep 30, 2024 | -3.08 Mn |
| Jun 30, 2024 | -2.77 Mn |
| Mar 31, 2024 | 1.85 Mn |
| Dec 31, 2023 | -1.65 Mn |
| Sep 30, 2023 | 75,854.22 |
| Jun 30, 2023 | -17,794.81 |
| Mar 31, 2023 | -55,139.29 |
| Dec 31, 2022 | -113,144.39 |
| Sep 30, 2022 | 17,602.76 |
| Jun 30, 2022 | 358,211.09 |
| Mar 31, 2022 | 151,593.17 |
| Dec 31, 2021 | -405,603.78 |
| Sep 30, 2021 | 132,873.75 |
| Jun 30, 2021 | -195,203.19 |
| Mar 31, 2021 | 600,590.07 |
| Dec 31, 2020 | -11,061.56 |
| Sep 30, 2020 | -155,350.27 |
| Jun 30, 2020 | -12,453.74 |
| Mar 31, 2020 | -402,166.32 |
| Dec 31, 2019 | -2.32 Mn |
| Sep 30, 2019 | -276,066.77 |
| Jun 30, 2019 | 511,618.95 |
| Mar 31, 2019 | 45,182.81 |
| Dec 31, 2018 | -2.31 Mn |
| Sep 30, 2018 | 1.32 Mn |
| Jun 30, 2018 | -403,334.12 |
| Mar 31, 2018 | 212,990.04 |